DETECTION OF TISSUE INTERLEUKIN-15 AND INTERFERON GAMMA IN ALOPECIA AREATA
Gohary, Y., Negm, M., Daoud, S., Kamel, H. (2025). DETECTION OF TISSUE INTERLEUKIN-15 AND INTERFERON GAMMA IN ALOPECIA AREATA. EKB Journal Management System, 6(1), 7-21. doi: 10.21608/ejmr.2024.220463.1418
Yasser Mostafa Gohary; Mona Ahmed Mandour Ahmed Negm; Sahar Aly Daoud; Hanan Abdelrazik Kamel. "DETECTION OF TISSUE INTERLEUKIN-15 AND INTERFERON GAMMA IN ALOPECIA AREATA". EKB Journal Management System, 6, 1, 2025, 7-21. doi: 10.21608/ejmr.2024.220463.1418
Gohary, Y., Negm, M., Daoud, S., Kamel, H. (2025). 'DETECTION OF TISSUE INTERLEUKIN-15 AND INTERFERON GAMMA IN ALOPECIA AREATA', EKB Journal Management System, 6(1), pp. 7-21. doi: 10.21608/ejmr.2024.220463.1418
Gohary, Y., Negm, M., Daoud, S., Kamel, H. DETECTION OF TISSUE INTERLEUKIN-15 AND INTERFERON GAMMA IN ALOPECIA AREATA. EKB Journal Management System, 2025; 6(1): 7-21. doi: 10.21608/ejmr.2024.220463.1418

DETECTION OF TISSUE INTERLEUKIN-15 AND INTERFERON GAMMA IN ALOPECIA AREATA

Egyptian Journal of Medical Research
Volume 6, Issue 1, January 2025, Page 7-21  XML PDF (849.42 K)
Document Type: Original Article
DOI: 10.21608/ejmr.2024.220463.1418
View on SCiNiTO View on SCiNiTO
Authors
Yasser Mostafa Goharyorcid 1; Mona Ahmed Mandour Ahmed Negm email 2; Sahar Aly Daoud3; Hanan Abdelrazik Kamel2
1Dermatology and Andrology Department, Faculty of Medicine, Beniseuf University, Egypt
2Dermatology & Venereology department, Faculty of Medicine, Beni-Suef University, Egypt
3Pathology department, Faculty of Medicine, Beni-Suef University, Egypt
Abstract
The current study was designed with an aim to evaluate immune staining expression of IFN-γ and IL-15 in patients with AA (between lesional and non-lesional skin biopsies) assessing their relationship to clinical parameters of the diseases. It was a case-control study, including thirty-six patients with localized, recent onset AA, a 3.5 mm punch skin biopsies were taken from lesional and non-lesional skin 5 cm away from the lesion of every patient as a control group for immunohistochemical analysis of IL15 and IFN-γ. The level of IL15 and IFN-γ show correlation with the severity of inflammation as they were higher in the more severe cases and who has multiple lesions. They show non-statistically differences between healthy skin biopsy and lesional skin biopsy. There were neither affected by the subject's age and site and extent of lesion. We can conclude that skin of severe cases of AA has a high level of IL15 and IFN-γ than localized and mild cases
Keywords
Keywords: IL15; IFN-γ; Alopecia Areata (AA)
References
  1. Seetharam KA. Alopecia areata: an update. Indian J Dermatol Venereol Leprol. 2013 Sep-Oct;79(5):563-75. doi: 10.4103/0378-6323.116725. PMID: 23974575.
  2. Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017 Mar 16;3:17011. doi: 10.1038/nrdp.2017.11. PMID: 28300084; PMCID: PMC5573125.
  3. Agre K, McCarthy Veach P, Bemmels H, Wiens K, LeRoy BS, Hordinsky M. Familial implications of autoimmune disease: Recurrence risks of alopecia areata and associated conditions in first-degree relatives. J Genet Couns. 2020 Feb;29(1):35-43. doi: 10.1002/jgc4.1178. Epub 2019 Oct 11. PMID: 31605426.
  4. Lepe K, Zito PM. Alopecia Areata. 2022 Aug 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 30725685.
  5. Juárez-Rendón KJ, Rivera Sánchez G, Reyes-López MÁ, García-Ortiz JE, Bocanegra-García V, Guardiola-Avila I, Altamirano-García ML. Alopecia Areata. Current situation and perspectives. Arch Argent Pediatr. 2017 Dec 1;115(6):e404-e411. English, Spanish. doi: 10.5546/aap.2017.eng.e404. PMID: 29087123.
  6. Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options. Int J Trichology. 2018 Mar-Apr;10(2):51-60. doi: 10.4103/ijt.ijt_99_17. PMID: 29769777; PMCID: PMC5939003.
  7. Paus R, Bulfone-Paus S, Bertolini M. Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management. J Investig Dermatol Symp Proc. 2018 Jan;19(1):S12-S17. doi: 10.1016/j.jisp.2017.10.014. PMID: 29273098.
  8. Kasumagic-Halilovic E, Prohic A, Karamehic J. Serum concentrations of interferon-gamma (IFN-g) in patients with alopecia areata: correlation with clinical type and duration of the disease. Med Arh. 2010;64(4):212-4. PMID: 21246917.
  9. Ünlü B, Türsen Ü, Rajabi Z, Jabalameli N, Rajabi F. The Immunogenetics of Systemic Sclerosis. Adv Exp Med Biol. 2022;1367:259-298. doi: 10.1007/978-3-030-92616-8_10. PMID: 35286699.
  10. Ryu S, Lee Y, Hyun MY, Choi SY, Jeong KH, Park YM, Kang H, Park KY, Armstrong CA, Johnson A, Song PI, Kim BJ. Mycophenolate antagonizes IFN-γ-induced catagen-like changes via β-catenin activation in human dermal papilla cells and hair follicles. Int J Mol Sci. 2014 Sep 22;15(9):16800-15. doi: 10.3390/ijms150916800. PMID: 25247578; PMCID: PMC4200814.
  11. Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D. Cytokines and other mediators in alopecia areata. Mediators Inflamm. 2010;2010:928030. doi: 10.1155/2010/928030. Epub 2010 Mar 11. PMID: 20300578; PMCID: PMC2837895.
  12. Ebrahim AA, Salem RM, El Fallah AA, Younis ET. Serum Interleukin-15 is a Marker of Alopecia Areata Severity. Int J Trichology. 2019 Jan-Feb;11(1):26-30. doi: 10.4103/ijt.ijt_80_18. PMID: 30820130; PMCID: PMC6385510.
  13. Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, de Jong A, Harel S, DeStefano GM, Rothman L, Singh P, Petukhova L, Mackay-Wiggan J, Christiano AM, Clynes R. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014 Sep;20(9):1043-9. doi: 10.1038/nm.3645. Epub 2014 Aug 17. PMID: 25129481; PMCID: PMC4362521.
  14. Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017 Mar 16;3:17011. doi: 10.1038/nrdp.2017.11. PMID: 28300084; PMCID: PMC5573125.
  15. Alshahrani AA, Al-Tuwaijri R, Abuoliat ZA, Alyabsi M, AlJasser MI, Alkhodair R. Prevalence and Clinical Characteristics of Alopecia Areata at a Tertiary Care Center in Saudi Arabia. Dermatol Res Pract. 2020 Mar 13;2020:7194270. doi: 10.1155/2020/7194270. PMID: 32231700; PMCID: PMC7093899.
  16. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41-101. doi: 10.1016/S0065-2776(07)96002-2. PMID: 17981204.
  17. McElwee KJ, Gilhar A, Tobin DJ, Ramot Y, Sundberg JP, Nakamura M, Bertolini M, Inui S, Tokura Y, King LE Jr, Duque-Estrada B, Tosti A, Keren A, Itami S, Shoenfeld Y, Zlotogorski A, Paus R. What causes alopecia areata? Exp Dermatol. 2013 Sep;22(9):609-26. doi: 10.1111/exd.12209. PMID: 23947678; PMCID: PMC4094373.
  18. Agamia N, Apalla Z, El Achy S, Abdelmaksoud E, Kandil N, Abozeid S. Interferon-gamma serum level and immunohistochemical expression of CD8 cells in tissue biopsies in patients with alopecia areata in correlation with trichoscopic findings. Dermatol Ther. 2020 Jul;33(4):e13718. doi: 10.1111/dth.13718. Epub 2020 Jul 5. PMID: 32472615.
  19. Arca E, Muşabak U, Akar A, Erbil AH, Taştan HB. Interferon-gamma in alopecia areata. Eur J Dermatol. 2004 Jan-Feb;14(1):33-6. PMID: 14965793.
  20. Kasumagic-Halilovic E, Prohic A, Karamehic J. Serum concentrations of interferon-gamma (IFN-g) in patients with alopecia areata: correlation with clinical type and duration of the disease. Med Arh. 2010;64(4):212-4. PMID: 21246917.
  21. Lortkipanidze NT, Tevzadze MSh, Kamkamidze GK. [Interferon-gamma and neopterin in alopecia areata]. Georgian Med News. 2005 Jun;(123):53-7. Russian. PMID: 16052058.
  22. Ataseven A, Saral Y, Godekmerdan A. Serum cytokine levels and anxiety and depression rates in patients with alopecia areata. Eurasian J Med. 2011 Aug;43(2):99-102. doi: 10.5152/eajm.2011.22. PMID: 25610172; PMCID: PMC4261352.
  23. Tabara K, Kozłowska M, Jędrowiak A, Bienias W, Kaszuba A. Serum concentrations of selected proinflammatory cytokines in children with alopecia areata. Postepy Dermatol Alergol. 2019 Feb;36(1):63-69. doi: 10.5114/ada.2019.82826. Epub 2019 Feb 22. PMID: 30858781; PMCID: PMC6409873.
  24. Damsky W, King BA. JAK inhibitors in dermatology: The promise of a new drug class. J Am Acad Dermatol. 2017 Apr;76(4):736-744. doi: 10.1016/j.jaad.2016.12.005. Epub 2017 Jan 28. PMID: 28139263; PMCID: PMC6035868.
  25. Kim WH, An HJ, Kim JY, Gwon MG, Gu H, Lee SJ, Park JY, Park KD, Han SM, Kim MK, Park KK. Apamin inhibits TNF-α- and IFN-γ-induced inflammatory cytokines and chemokines via suppressions of NF-κB signaling pathway and STAT in human keratinocytes. Pharmacol Rep. 2017 Oct;69(5):1030-1035. doi: 10.1016/j.pharep.2017.04.006. Epub 2017 Apr 18. PMID: 28958612.
  26. Tabara K, Kozłowska M, Jędrowiak A, Bienias W, Kaszuba A. Serum concentrations of selected proinflammatory cytokines in children with alopecia areata. Postepy Dermatol Alergol. 2019 Feb;36(1):63-69. doi: 10.5114/ada.2019.82826. Epub 2019 Feb 22. PMID: 30858781; PMCID: PMC6409873.
  27. Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. PMID: 34741573; PMCID: PMC9298335.
Statistics
Article View: 260
PDF Download: 138